Effect of the daily exposure of 1.7 GHz LTE electromagnetic field in early fetal brain development using a human brain organoid model of the cerebral cortex DOI Creative Commons

G. Park,

Yuanjiang Pan, Yoon Jeong Choi

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

Abstract Wireless communication technology’s ubiquity means constant exposure to radiofrequency electromagnetic fields (RF-EMF). While concerns exist about RF-EMF’s effects on fetal brain development, studying this in pregnant women poses ethical and safety challenges. Our study examined 1.7 GHz LTE impact early human development using organoids derived from induced pluripotent stem cells (hiPSCs). Previous research showed that 100-day-old cerebral cortical correspond 19-24 weeks post-conception of development. We exposed RF-EMF at 8 W/kg specific absorption rate (SAR) for 5 hours daily up 100 days. monitored size, developmental morphology, stage markers immunofluorescence microscopy qPCR analysis. Comparing RF-EMF-exposed with controls no significant differences or expression key markers: SOX2 PAX6 (pluripotent cell markers), NEUN (mature neuronal marker), MAP2 (dendrite SYN1 (synapse marker). Results suggest SAR may not significantly affect

Язык: Английский

Brain organoid protocols and limitations DOI Creative Commons
Helen Zhao, Gabriel G. Haddad

Frontiers in Cellular Neuroscience, Год журнала: 2024, Номер 18

Опубликована: Март 20, 2024

Stem cell-derived organoid technology is a powerful tool that revolutionizes the field of biomedical research and extends scope our understanding human biology diseases. Brain organoids especially open an opportunity for brain modeling many neurological diseases, which have lagged due to inaccessibility samples lack similarity with other animal models. can be generated through various protocols mimic whole or region-specific. To provide overview technology, we summarize currently available list several factors consider before choosing protocols. We also outline limitations current challenges need solved in future investigation development pathobiology.

Язык: Английский

Процитировано

15

Modelling human brain development and disease with organoids DOI
Marcella Birtele, Madeline A. Lancaster, Giorgia Quadrato

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2024, Номер unknown

Опубликована: Дек. 12, 2024

Язык: Английский

Процитировано

11

Stem Cell–Based Organoid Models of Neurodevelopmental Disorders DOI
Lu Wang,

Charlotte Owusu-Hammond,

David Sievert

и другие.

Biological Psychiatry, Год журнала: 2023, Номер 93(7), С. 622 - 631

Опубликована: Янв. 25, 2023

Язык: Английский

Процитировано

20

Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders DOI Open Access

Hamed Massoumi,

Sohil Amin, Mohammad Soleimani

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(10), С. 9006 - 9006

Опубликована: Май 19, 2023

Extracellular vesicles (EVs) have been recognized as promising candidates for developing novel therapeutics a wide range of pathologies, including ocular disorders, due to their ability deliver diverse array bioactive molecules, proteins, lipids, and nucleic acids, recipient cells. Recent studies shown that EVs derived from various cell types, mesenchymal stromal cells (MSCs), retinal pigment epithelium cells, endothelial therapeutic potential in such corneal injury diabetic retinopathy. exert effects through mechanisms, promoting survival, reducing inflammation, inducing tissue regeneration. Furthermore, promise nerve regeneration diseases. In particular, MSCs demonstrated promote axonal functional recovery animal models optic glaucoma. contain neurotrophic factors cytokines can enhance neuronal survival regeneration, angiogenesis, modulate inflammation the retina nerve. Additionally, experimental models, application delivery platform molecules has revealed great treatment disorders. However, clinical translation EV-based therapies faces several challenges, further preclinical are needed fully explore disorders address challenges successful translation. this review, we will provide an overview different types cargo, well techniques used isolation characterization. We then review explored role highlighting need be addressed Finally, discuss future directions Overall, aims comprehensive current state art ophthalmic with focus on

Язык: Английский

Процитировано

18

A Shared Pathogenic Mechanism for Valproic Acid and SHROOM3 Knockout in a Brain Organoid Model of Neural Tube Defects DOI Creative Commons
Taylor N. Takla, Jinghui Luo,

Roksolana Sudyk

и другие.

Cells, Год журнала: 2023, Номер 12(13), С. 1697 - 1697

Опубликована: Июнь 23, 2023

Neural tube defects (NTDs), including anencephaly and spina bifida, are common major malformations of fetal development resulting from incomplete closure the neural tube. These conditions lead to either universal death (anencephaly) or severe lifelong complications (spina bifida). Despite hundreds genetic mouse models defect phenotypes, genetics human NTDs poorly understood. Furthermore, pharmaceuticals, such as antiseizure medications, have been found clinically increase risk when administered during pregnancy. Therefore, a model that recapitulates neurodevelopment would be immense benefit understand underlying identify teratogenic mechanisms. Using our self-organizing single rosette cortical organoid (SOSR-COs) system, we developed high-throughput image analysis pipeline for evaluating SOSR-CO structure NTD-like phenotypes. Similar small molecule inhibition apical constriction, medication valproic acid (VPA), known cause NTDs, increases lumen size cell surface area in dose-responsive manner. GSK3β HDAC inhibitors caused similar expansion; however, RNA sequencing suggests VPA does not inhibit at these concentrations. The knockout SHROOM3, well-known NTD-related gene, also expansion lumen, well reduced f-actin polarization. increased sizes were by suggesting impingement this process is shared mechanism treatment SHROOM3-KO, two causes NTDs. Our system allows rapid identification phenotypes both compounds variants should prove useful understanding specific NTD mechanisms predicting drug teratogenicity.

Язык: Английский

Процитировано

12

Emerging approaches to enhance human brain organoid physiology DOI Creative Commons
Anna Pagliaro, Benedetta Artegiani, Delilah Hendriks

и другие.

Trends in Cell Biology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Brain organoids are important 3D models for studying human brain development, disease, and evolution. To overcome some of the existing limitations that affect organoid quality, reproducibility, characteristics, in vivo resemblance, current efforts directed to improve their physiological relevance by exploring different, yet interconnected, routes. In this review, these approaches latest developments discussed, including stem cell optimization, refining morphogen administration strategies, altering extracellular matrix (ECM) niche, manipulating tissue architecture mimic morphogenesis. Additionally, strategies increase diversity enhance maturation, such as establishing co-cultures, assembloids, xenotransplantation, reviewed. We explore how various factors can be tuned intermingled speculate on future avenues towards even more physiologically-advanced organoids.

Язык: Английский

Процитировано

0

In vitro liver models for toxicological research DOI
Ichiro Fukunaga, Takanori Takebe

Drug Metabolism and Pharmacokinetics, Год журнала: 2025, Номер unknown, С. 101478 - 101478

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Bioengineering innovations for neural organoids with enhanced fidelity and function DOI
Yubing Sun, Yoshiho Ikeuchi, Feng Guo

и другие.

Cell stem cell, Год журнала: 2025, Номер 32(5), С. 689 - 709

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0

Brain organoids: A new tool for modelling of neurodevelopmental disorders DOI Creative Commons
Yirizhati Aili, Nuersimanguli Maimaitiming, Zengliang Wang

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(17)

Опубликована: Сен. 1, 2024

Abstract Neurodevelopmental disorders are mostly studied using mice as models. However, the mouse brain lacks similar cell types and structures those of human brain. In recent years, emergence three‐dimensional organoids derived from embryonic stem cells or induced pluripotent allows for controlled monitoring evaluation early neurodevelopmental processes has opened a window studying various aspects development. such lack original anatomical structure during maturation, maturation that rely on unique cellular interactions neural network connections limited. Consequently, difficult to be used extensively effectively while modelling later stages development disease progression. To address this problem, several methods technologies have emerged aim enhance sophisticated regulation developmental through bioengineering approaches, which may alleviate some current limitations. This review discusses advances application areas organoid culture methods, aiming generalize optimization strategies systems, improve ability mimic development, value organoids.

Язык: Английский

Процитировано

3

RosetteArray Platform for Quantitative High-Throughput Screening of Human Neurodevelopmental Risk DOI Creative Commons
Brady F. Lundin, Gavin Knight, Nikolai J. Fedorchak

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Апрель 2, 2024

SUMMARY Neural organoids have revolutionized how human neurodevelopmental disorders (NDDs) are studied. Yet, their utility for screening complex NDD etiologies and in drug discovery is limited by a lack of scalable quantifiable derivation formats. Here, we describe the RosetteArray ® platform’s ability to be used as an off-the-shelf, 96-well plate assay that standardizes incipient forebrain spinal cord organoid morphogenesis micropatterned, 3-D, singularly polarized neural rosette tissues (>9000 per plate). RosetteArrays seeded from cryopreserved pluripotent stem cells, cultured over 6-8 days, immunostained images can quantified using artificial intelligence-based software. We demonstrate suitability developmental neurotoxicity genetic environmental factors known cause tube defect risk. Given presence perturbation models NDDs neurodegenerative disorders, platform could enable quantitative high-throughput (qHTS) risk across regulatory precision medicine applications.

Язык: Английский

Процитировано

2